Bristol-Myers Squibb Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance
July 25, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.18, $0.12 better than the analyst estimate of $1.06. Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $6.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2019 EPS of $4.20-$4.30, versus the consensus of... More
